Navigation Links
RxAlly Adds Accomplished Clinical Services Expert And Pharmacist, Rebecca Chater, To The Company's Leadership Team
Date:12/4/2012

LEESBURG, Va., Dec. 4, 2012 /PRNewswire/ -- RxAlly, a first-of-its-kind alliance of more than 22,000 pharmacies nationwide, announced today that Rebecca Chater, RPh, MPH, FAPhA, has joined the company's leadership team as Vice President of Health Outcomes.  In this role, Ms. Chater will be responsible for providing leadership and clinical management of RxAlly solutions, as well as integrating business development with clinical staff and operations.

Ms. Chater brings to RxAlly more than 20 years of experience leading innovative clinical services programs and launching community pharmacy initiatives proven to enhance patient health outcomes and lower health care costs, including the highly regarded Asheville Project.

"Rebecca's impressive credentials and extensive track record of success speaks to both her tremendous expertise and her genuine passion for enhancing the value of community-based, patient-focused, quality pharmacy care.  We are very fortunate to have her on board," said Bruce Roberts, CEO of RxAlly. "Her role will be critical in helping RxAlly develop and implement on a national scale industry-leading clinical service programs that support RxAlly's member pharmacies in providing the highest quality pharmacy care available."

Most recently, Rebecca Chater served as an Executive Vice President at Kerr Health, a North Carolina-based local chain of 77 community pharmacies which spearheaded development and implementation of patient-centric pharmacy care, health screening and disease management services in local pharmacies across the state, including urban and rural locations.  While at Kerr, Rebecca provided clinical leadership in the Specialty, Long Term Care and Care Management divisions, including developing and implementing an integrated model of clinical programs that optimized patient outcomes, ensured clinical efficiencies and controlled costs.  She also collaborated with other executive leaders to develop and implement an organizational strategic plan, identify gaps and design solutions for performance improvement, and provide guidance and oversight for two key Medical Home projects enacted by the North Carolina General Assembly. 

"RxAlly's goal is to empower community pharmacies to provide personalized pharmacist care to improve health outcomes and lower health care costs, so it's a perfect fit with what I have been focusing on professionally for a long time," Chater said.  "I am particularly excited at the prospect of working alongside RxAlly's highly-capable leadership team and with the many forward-thinking and dedicated pharmacists at the local level to help advance pharmacy care on a national scale."

Ms. Chater's other prior professional roles include serving as President of KDI Health Solutions, LLC, and playing an instrumental role in the Asheville Project, which serves as a model for delivering health solutions and patient-centric care through community pharmacy.  Ms. Chater is an Elected Member and Past-President of the North Carolina Board of Pharmacy and has served as Visiting Clinical Assistant Professor in the Department of Pharmacotherapy at the University Of North Carolina Eshelman School of Pharmacy.  She earned both her Master's Degree in Public Health and her Bachelor of Science in Pharmacy at the University of North Carolina at Chapel Hill.

RxAlly is a performance network of aligned pharmacies, united to help patients achieve better health through personalized pharmacist care while reducing costs.  The company was developed to provide a new solution to the critical issues of providing additional access to care and ensuring effective health care spending at a time when prescription medicine misuse is associated with $290 billion in annual costs.  For media inquiries, please contact: 5W Public Relations.

About RxAlly
With more than 22,000 member pharmacies nationwide, RxAlly has brought together the largest national network of pharmacies to improve health and lower costs. The RxAlly Performance Network of community pharmacies aims to improve health through personalized pharmacist care, clinical research and evidence-based clinical practices, and an interoperable technology platform. By advancing the role of pharmacists, RxAlly is facilitating new solutions as it leads an innovative approach to health care that aligns the interests of patients, pharmacists and payers. For more information, please visit us at: www.RxAlly.com, on Facebook or Twitter.

Contact:

Susan Weingram / 5W Public Relations


O: 212-584-4271 / E: sweingram@5wpr.com


'/>"/>
SOURCE RxAlly
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RxAlly Member Pharmacies Invited To Become The Preferred Network For Smart Insurance Company Holdings, Inc.
2. RxAlly Strengthens Leadership Team With New Chief Information Officer Mike Groh
3. RxAlly Adds Nationally Recognized Health Care Policy Professional Wayne Oliver To The Companys Leadership Team
4. RxAlly Announces Addition Of Experienced Corporate Counsel Tom OGrady To The Companys Leadership Team
5. RxAlly Opens Its Doors In Leesburg, Virginia
6. RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies
7. Gynecologic Oncology Publishes New Clinical Study Showing Positive Performance of OVA1, Vermillions Ovarian Cancer Test
8. Elseviers Clinical Pharmacology Now Accessible Through Elsevier Infobutton
9. ClinicalKey Key Innovator Award to Recognize the Innovative Use of Health Information and Technology to Save and Improve Lives
10. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... FL (PRWEB) , ... June 24, 2016 , ... Finally, ... common after venous procedures, dermaka cream can be incorporated into the post-surgical treatment plans ... minor surgical procedures. , dermaka cream is very effective for bruising and causes ...
Breaking Medicine News(10 mins):